Labour market · 03/11/2010Updated: 10/17/2026 · 1 min read

Compass Group USA, Inc. Faces Negative Determination on Reconsideration for Canteen in Webster City, Iowa

Summary

Compass Group USA, Inc. has received a negative determination on reconsideration for its Canteen facility in Webster City, Iowa, following a review by the relevant authorities

Original source language: Federal Register — Department of LaborOpen original release →

Add your company to Business Communicator

We monitor business sources and connect attention with companies, profiles and services available in Business Communicator.

Create a free company profile Explore businesses on Business Maps →

Create a free company profile →

Explore insights

Business insights →

Global Markets News Trade Regulation News Business Technology News Fintech for Business: Payments & Banking News Supply Chain News Central Bank Policy News

Related business signals

Labour market · 10/23/2026

Georgiamune and Menarini Group sign exclusive global licensing and collaboration agreement for GIM-621

- Georgiamune and Menarini Group sign an exclusive global licensing and collaboration agreement for GIM-621, a pioneering oral immuno-oncological agent in its class GIM621 is a small molecule ad...

Read summary →

Labour market · 10/23/2026

MAXHUB is bringing full-scenario collaboration solutions to InfoComm América Latina 2026

Mexico City, Oct. 22, 2026 — MAXHUB, ranked Global No. 11 in both collaboration boards and all-in-one LED displays, is showcasing solutions for education, corporate collaboration and commercial display at...

Read summary →

Labour market · 10/22/2026

Georgiamune and the Menarini Group conclude an exclusive global licensing and collaboration agreement on GIM-621, an innovative oral immuno-oncological agent

GIM-621 is an innovative, preclinical, small molecule oral immunotherapy that has potential for application in the treatment of several solid tumours.

Read summary →

Labour market · 10/22/2026

Georgiamune and Menarini Group enter into an exclusive global license and collaboration agreement for GIM-621, a first-in-class oral immuno-oncology agent

GIM-621 is a preclinical stage, first-in-class oral small molecule immunotherapy with potential application across multiple solid tumors.

Read summary →

Labour market · 10/22/2026

Corra Group offers electronic I-9 services as the Employment Verification Evolves

As the verification of employment eligibility evolves, Corra Group offers electronic I-9 tools designed to help employers manage forms, deadlines and E-Verify workflows. EL SEGUNDO, Calif., Oct. 22, 2026 — For...

Read summary →